Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
19.08
-0.01 (-0.05%)
Jul 31, 2026, 4:08 PM HKT

HKG:2190 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
244.37100.26-78.73-113.56-199.69
Depreciation & Amortization
36.9136.9235.2326.2713.38
Other Amortization
0.720.930.65--
Loss (Gain) From Sale of Assets
0.090.050.599.13-0.02
Asset Writedown & Restructuring Costs
0.996.74---
Loss (Gain) From Sale of Investments
0.6336.258.53-4.78-13.93
Loss (Gain) on Equity Investments
-1.1---
Stock-Based Compensation
28.723.7485.7787.6876.21
Other Operating Activities
3.05-19.1113.63-23.525
Change in Accounts Receivable
-6.83-0.35-0.17-0.57-0.33
Change in Inventory
29.65-38.93-47.3-61.97-28.28
Change in Accounts Payable
40.1724.9436.3936.7644.55
Change in Other Net Operating Assets
6.421.5543.86-46.75-13.11
Operating Cash Flow
384.86174.0898.44-91.32-116.21
Operating Cash Flow Growth
121.09%76.83%---

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-111.22-191.34-190.92-134.74-78.11
Sale of Property, Plant & Equipment
0.420.070.39-0.11
Sale (Purchase) of Intangibles
----10.55-11.49
Investment in Securities
62.06-617.81-24.3950.24-1,239
Other Investing Activities
4.077.728.67--
Investing Cash Flow
-44.68-801.36-206.24-95.05-1,328

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
1398750-5
Long-Term Debt Repaid
-169.5-54.58-6.41-4.89-39.2
Net Debt Issued (Repaid)
-30.532.4243.59-4.89-34.2
Issuance of Common Stock
9.810.06--2,968
Repurchase of Common Stock
-119.6-72.28-53.8-24.64-9.15
Common Dividends Paid
-32.69----
Other Financing Activities
-1.02-2.18-1.25-0.72-115.06
Financing Cash Flow
-174-41.98-11.46-30.262,810

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-4.740.790.543.57-6.46
Net Cash Flow
161.45-668.47-118.72-213.061,359

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
273.64-17.26-92.48-226.06-194.32
Free Cash Flow Growth
-----
Free Cash Flow Margin
25.88%-2.21%-17.52%-67.66%-109.22%
Free Cash Flow Per Share
0.85-0.05-0.28-0.68-0.66
Levered Free Cash Flow
128.66-153.23-53.44-226.74-129.84
Unlevered Free Cash Flow
129.3-151.87-52.65-226.29-129.65

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
1.022.181.250.720.31
Change in Working Capital
69.41-12.7932.78-72.542.83